Biomarkers of HIV immune reconstitution inflammatory syndrome

被引：67

作者：

Bonham, Shuli ^{[1
]}

Meya, David B. ^{[2
]}

Bohjanen, Paul R. ^{[1
]}

Boulware, David R. ^{[1
]}

机构：

[1] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA

[2] Makerere Univ, Infect Dis Inst, Kampala, Uganda

来源：

BIOMARKERS IN MEDICINE | 2008年 / 2卷 / 04期

关键词：

biomarkers; cytokine's; HAART; HIV/AIDS; IRIS; T cells;

D O I：

10.2217/17520363.2.4.349

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Dysregulation of the immune system drives HIV pathogenesis. As we develop new ways to treat HIV and AIDS, we encounter new clinical ramifications of our treatment on regulatory components of the immune system. HIV-associated immune reconstitution inflammatory syndrome (IRIS) occurs after the initiation of antiretroviral therapy with inappropriate and unbalanced restoration of the immune system, resulting in pathologic inflammatory reactions with significant morbidity. IRIS is most commonly associated with latent, occult or past infections, including tuberculosis, Cryptococcus neoformans and Mycobacterium avium complex. We discuss common clinical presentations, new diagnostic modalities, current hypotheses of IRIS pathogenesis and future directions of IRIS-related research, focusing on the identification of biomarkers that can be used to predict and diagnose IRIS.

引用

页码：349 / 361

页数：13

共 63 条

[1] Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients [J].

Al-Harthi, L ;

Voris, J ;

Patterson, BK ;

Becker, S ;

Eron, J ;

Smith, KY ;

D'Amico, R ;

Mildvan, D ;

Snidow, J ;

Pobiner, B ;

Yau, L ;

Landay, A .

HIV MEDICINE, 2004, 5 (01) :55-65

[2] A case for treating high hepatitis B DNA levels before starting HIV therapy [J].

Baker, Jason V. ;

Boulware, David R. ;

Bohjanen, Paul R. .

AIDS, 2006, 20 (18) :2402-2403

[3]

Barry S M, 2002, HIV Med, V3, P207, DOI 10.1046/j.1468-1293.2002.00115.x

[4] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].

Bettelli, E ;

Carrier, YJ ;

Gao, WD ;

Korn, T ;

Strom, TB ;

Oukka, M ;

Weiner, HL ;

Kuchroo, VK .

NATURE, 2006, 441 (7090) :235-238

[5] Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: The role of fluconazole resistance and immune reconstitution [J].

Bicanic, Tihana ;

Harrison, Thomas ;

Niepieklo, Alina ;

Dyakopu, Nontobeko ;

Meintjes, Graeme .

CLINICAL INFECTIOUS DISEASES, 2006, 43 (08) :1069-1073

[6] Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients [J].

Bourgarit, A ;

Carcelain, G ;

Martinez, V ;

Lascoux, C ;

Delcey, V ;

Gicquel, B ;

Vicaut, E ;

Lagrange, PH ;

Sereni, D ;

Autran, B .

AIDS, 2006, 20 (02) :F1-F7

[7] Determinants of immune reconstitution inflammatory syndrome in HIV type 1 -: Infected patients with tuberculosis after initiation of antiretroviral therapy [J].

Breton, G ;

Duval, X ;

Estellat, C ;

Poaletti, X ;

Bonnet, D ;

Mvondo, DM ;

Longuet, P ;

Leport, C ;

Vildé, JL .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (11) :1709-1712

[8] Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues [J].

Bucy, RP ;

Hockett, RD ;

Derdeyn, CA ;

Saag, MS ;

Squires, K ;

Sillers, M ;

Mitsuyasu, RT ;

Kilby, JM .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (10) :1391-1398

[9]

Burman W, 2007, INT J TUBERC LUNG D, V11, P1282

[10] Multiple cerebral cryptococcomas associated with immune reconstitution in HIV-1 infection [J].

Cattelan, AM ;

Trevenzoli, M ;

Sasset, L ;

Lanzafame, M ;

Marchioro, U ;

Meneghetti, F .

AIDS, 2004, 18 (02) :349-351

← 1 2 3 4 5 6 7 →